The appointment of a new CFO typically signals a strategic shift or reinforcement in a company's financial strategy, which can positively influence investor confidence and the company's future growth trajectory. Given Thomas Timko's role and the nature of the announcement, it is reasonable to expect a positive short-term impact on DBD's stock price.